Výsledky vyhledávání - "Laura T. McWhorter"

Open-label trial evaluating the safety and efficacy of zoledronic acid in preventing bone loss in patients with hormone-sensitive prostate cancer and bone metastases

Autor: Robert Given, Craig Barkley, David L. Bilhartz, James C. Vestal, Sydney R. Julian, Leo V. Lacerna, Thomas J. Polascik, Laura T. McWhorter, Charles K. Metzger, Gary S. Karlin

Publikováno v: Urology. 66:1054-1059

Objectives To evaluate the efficacy and safety of zoledronic acid in preventing bone loss in patients with hormone-sensitive prostate cancer and bone metastases who were receiving androgen deprivation therapy. Methods Patients received zoledronic aci

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1f79b71dbf40562a7ad83a8a0dfcb72
https://doi.org/10.1016/j.urology.2005.05.035

Zobrazit plný text záznamu

[Untitled]

Autor: James P. Gilligan, Peidi Hu, Patrick J. Sinko, Curtis L. Smith, Erik J. Wagner, John P. Sutyak, Vijaya D. Makhey, Lisa M. Falzone, Laura T. McWhorter, Yong-Hee Lee, William Stern, Hongshi Yu, Glen D. Leesman, Barbara A. Perry

Publikováno v: Pharmaceutical Research. 16:527-533

Purpose. To evaluate a biopharmaceutical approach for selecting formulation additives and establishing the performance specifications of an oral peptide delivery system using sCT as a model peptide. Methods. The effect of formulation additives on sCT

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::110f75ee79d3563646f90810b7907487
https://doi.org/10.1023/a:1018819012405

Zobrazit plný text záznamu

Lifestyle factors and duration of androgen deprivation affect bone mineral density of patients with prostate cancer during first year of therapy

Autor: Dezheng Huo, Tomasz M. Beer, James W. Stallings, Laura T. McWhorter, Christopher W. Ryan, Ronald L. Davis

Publikováno v: Urology. 70(1)

Objectives Androgen deprivation therapy (ADT) is associated with loss of bone mineral density (BMD) and increased fracture risk. We sought to examine the impact of ADT and lifestyle variables on BMD in 120 patients with prostate cancer without bone m

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16f296d1c44f8c36709bf141a912b9bb
https://pubmed.ncbi.nlm.nih.gov/17656221

Zobrazit plný text záznamu

Utility of pharmacodynamic measures for assessing the oral bioavailability of peptides. 1. Administration of recombinant salmon calcitonin in rats

Autor: Curtis L. Smith, James P. Gilligan, Erik J. Wagner, Patrick J. Sinko, Laura T. McWhorter, William Stern

Publikováno v: Journal of pharmaceutical sciences. 84(11)

Salmon calcitonin (sCT) is a therapeutic peptide used in the treatment of Paget's Disease, postmenopausal osteoporosis, and hypercalcemia due to malignancy. In this study, recombinant sCT (rsCT) was administered intravenously (iv), subcutaneously (sc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0b7103c1e629e1c39f81c5b6b49d72a
https://pubmed.ncbi.nlm.nih.gov/8587058

Zobrazit plný text záznamu

821: Early Association Between Duration of Androgen Deprivation, Life-Style Factors and Bone Mineral Density in Patients with Prostate Cancer: An Analysis During the First 12 Months of Therapy

Autor: Tomasz M. Beer, Dezheng Huo, Ronald L. Davis, Christopher W. Ryan, Laura T. McWhorter, J. Walt Stallings

Publikováno v: Journal of Urology. 173:222-222

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6607fc6f0cf7707ec521f539853f492f
https://doi.org/10.1016/s0022-5347(18)34990-5

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání